The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
Open accessAbstract
Arene oxide metabolites of aromatic anticonvulsants (phenytoin, phenobarbital, and carbamazepine) may be involved in the pathogenesis of hypersensitivity reactions. We investigated 53 patients with clinical sensitivity to anticonvulsants by exposing their lymphocytes in vitro to drug metabolites generated by a murine hepatic microsomal system. The diagnosis of a hypersensitivity reaction was corroborated by in vitro rechallenge for each drug (phenytoin, n = 34; phenobarbital, n = 22; carbamazepine, n = 25) when cytotoxicity (% dead cells) exceeded 3 SD above the mean result for controls. Cross-reactivity among the drugs was noted. 7 out of 10 patients who had received all three anticonvulsants had adverse reactions to each. 40 out of 50 patients tested to all three drugs in vitro were positive to each. Adverse reactions were indistinguishable among anti-convulsants. Skin rash (87%), fever (94%), hepatitis (51%), and hematologic abnormalities (51%) were common clinical features of each drug. 62% of reactions involved more than two organs. Cells from patients' parents exhibited in vitro toxicity that was intermediate between values for controls and patients. In vitro testing can help diagnose hypersensitivity to anticonvulsants. Cells from patients may also be used for prospective individualization of therapy to decrease risk of adverse reaction. Cross-reactivity among the major anticonvulsants is common and should be considered before deciding on alternative therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SODIUM DIPHENYL HYDANTOINATE IN THE TREATMENT OF CONVULSIVE DISORDERS
MERRITT, H. H. (1938) · Journal of the American Medical Association · doi:10.1001/jama.1938.02790380010004 · Cited by 457
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity
SHEAR, N. H., SPIELBERG, S. P., GRANT, D. M., TANG, B. K., & KALOW, W. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-179 · Cited by 373
Self-citationSaltzstein, S. L., & Ackerman, L. V. (1959) · Cancer · doi:10.1002/1097-0142(195901/02)12:1<164::aid-cncr2820120122>3.0.co;2-y · Cited by 327
Predisposition to Phenytoin Hepatotoxicity Assessed in Vitro
Spielberg, S. P., Gordon, G. B., Blake, D. A., Goldstein, D. A., & Herlong, H. F. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109243051302 · Cited by 234
Self-citationGENETIC PREDISPOSITION TO PHENYTOIN-INDUCED BIRTH DEFECTS
Strickler, S., Miller, M., Andermann, E., Dansky, L., Seni, M.-H., & Spielberg, S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90629-4 · Cited by 219
Self-citationDrug disposition and drug hypersensitivity
Kevin Park, B., Coleman, J. W., & Kitteringham, N. R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90706-4 · Cited by 199
Lertratanangkoon, K., & Horning, M. G. (1982) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07827-4 · Cited by 186
Anticonvulsant toxicity in vitro: possible role of arene oxides.
Spielberg, S. P., Gordon, G., Blake, D. A., Mellits, E. D., & Bross, D. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32544-9 · Cited by 139
Self-citationHaruda, F. D. (1979) · Neurology · doi:10.1212/wnl.29.11.1480 · Cited by 121
Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro
Gerson, W., Fine, D., Sp, S., & Sensenbrenner, L. (1983) · Blood · doi:10.1182/blood.v61.5.889.889 · Cited by 103
Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis
Sherertz, E. F., Jegasothy, B. V., & Lazarus, G. S. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)80012-8 · Cited by 81
Genetic variation in the human hepatic cytochrome P-450 system
KALOW, W. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00541288 · Cited by 76
Diphenylhydantoin interstitial nephritis. Roles of cellular and humoral immunologic injury
Hyman, L. R., Ballow, M. C., & Knieser, M. R. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80360-6 · Cited by 75
High incidence of a concentration-dependent skin reaction in children treated with phenytoin.
Wilson, J. T., Höjer, B., Tomson, G. B., Rane, A., & Sjöqvist, F. (1978) · BMJ · doi:10.1136/bmj.1.6127.1583 · Cited by 52
Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins
Pantarotto, C., Arboix, M., Sezzano, P., & Abbruzzi, R. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90372-0 · Cited by 49
Cited by
Severe Adverse Cutaneous Reactions to Drugs
Roujeau, J. C., & Stern, R. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311906 · Cited by 1,571
The DRESS Syndrome: A Literature Review
Cacoub, P., Musette, P., Descamps, V., Meyer, O., Speirs, C., Finzi, L., & Roujeau, J. C. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.017 · Cited by 1,012
Kardaun, S. H., Sekula, P., Valeyrie-Allanore, L., Liss, Y., Chu, C. Y., Creamer, D., Sidoroff, A., Naldi, L., Mockenhaupt, M., Roujeau, J. C., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12501 · Cited by 1,010
Bocquet, H., Bagot, M., & Roujeau, J. C. (1996) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(96)80038-1 · Cited by 964
Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., & Baillie, T. A. (2004) · Chemical Research in Toxicology · doi:10.1021/tx034170b · Cited by 706
Metadata
- Authors
- Shear, N. H., & Spielberg, S. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1988-12-01
- Volume
- 82
- Issue
- 6
- Pages
- 1826-1832
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2079198255
- Cited by
- 687
- References
- 15
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.